Atlas Trials

Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis

Clinical trial NCT00376129 · COMPLETED

Trial details

NCT number
NCT00376129
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2006-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.